ADVANTAN

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Germany, Estonia, Finland, Hong Kong, Croatia, Lithuania, Malta, Mexico, New Zealand, Poland, Romania, Turkey, United Kingdom, South Africa

Active ingredients

The drug ADVANTAN contains one active pharmaceutical ingredient (API):

1 Methylprednisolone UNII ET54W9J4U2 - METHYLPREDNISOLONE ACEPONATE

Methylprednisolone is a synthetic glucocorticoid and a methyl derivative of prednisolone. Methylprednisolone is a potent anti-inflammatory agent with the capacity to profoundly inhibit the immune system. Read about Methylprednisolone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ADVANTAN Cream, Ointment	Medicines and Medical Devices Safety Authority (NZ)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D07AC14	Methylprednisolone aceponate	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III)
Discover more medicines within D07AC14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10830B, 10833E, 10834F, 10835G, 10836H, 10838K, 10839L, 10840M, 10842P, 10843Q, 10844R, 10845T, 10846W, 10848Y, 10851D, 10852E, 10853F, 10855H, 10856J, 8054X, 8055Y, 8128T, 8618N
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 538912050012613, 538912050012713, 538912050016413, 541121020002517, 541121020002617, 541121020002717
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00259407, 00259413, 03113905, 03113911, 03113928, 03113934, 04939240, 04939257, 04939263, 04939292, 04939300, 04939317, 04939352, 04939369, 07376949
Country: EE	Ravimiamet	Identifier(s): 1028102, 1062009, 1133356, 1133367
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 381079
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 195224
Country: HK	Department of Health Drug Office	Identifier(s): 43662, 44065
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1000038, 1003228, 1004341, 1054536, 1075376, 1081252, 1085797, 1085837, 1089372, 1091519, 1091881
Country: MT	Medicines Authority	Identifier(s): MA024/01501, PI1438/10401A, PI908/11901A, PI908/11902A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 444M97
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 6260, 6261
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100074900, 100074923, 100074930, 100255429, 100345606, 100406236, 100406420, 100410491, 100413294, 100417719, 100418802, 100419457, 100419724, 100419919, 100451704, 100462748, 100462920, 100467025
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66593001, W66593002, W66594001, W66594002, W66594003, W66594004, W66594005, W66595001, W66595002, W66595003, W66595004, W66595005
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699514350255, 8699514350262, 8699514350316, 8699514380092, 8699514380108, 8699514380115, 8699514380122, 8699514480037
Country: ZA	Health Products Regulatory Authority	Identifier(s): 32/13.4.1/0361, 32/13.4.1/0362, X/13.4.1/384, X/13.4.1/385, X/13.4.1/386